Mikio Fujita
Mikio Fujita publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Screening and Detection and Colorectal Cancer Treatments and Studies.
- World rank
- #4,414,601 of 7,710,434 ranked researchers
- Rank in Japan
- #126,405 of 383,136
- Works
- 97
- Citations
- 1.5k
- Citations per work
- 15.9
What does Mikio Fujita research?
Mikio Fujita's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5152.5%
- Medicine5152.5%
- Everything else3535.9%
- Life Sciences1111.6%
- 1Pulmonary and Respiratory Medicine17% of their works
- 2Surgery16% of their works
- 3Oncology14% of their works
- 4Molecular Biology7% of their works
- 5Gastroenterology6% of their works
- 6Genetics5% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Genetic factors in colorectal cancer
- Metastasis and carcinoma case studies
- Esophageal Cancer Research and Treatment
Which keywords describe Mikio Fujita's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Molecular Characterization, Gastric Cancer, Lymph Node Dissection, Adjuvant Chemotherapy, Preoperative Chemoradiotherapy and Colorectal Cancer.
- Rectal Cancer
- Metastatic Carcinomas
- Laparoscopic Surgery
- Hereditary Syndromes
- Barrett's Esophagus
- Cetuximab
- Colorectal Cancer
- Adjuvant Chemotherapy
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Molecular Characterization
- Lymph Node Dissection
- Preoperative Chemoradiotherapy
- Screening
- KRAS Mutations
- Esophageal Carcinoma
- Imatinib Mesylate
- Lung Tumors
- Microsatellite Instability
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy302 topics
- Endoscopic Resection282 topics
- Molecular Characterization282 topics
- Gastric Cancer221 topic
- Lymph Node Dissection221 topic
- Adjuvant Chemotherapy122 topics
- Preoperative Chemoradiotherapy122 topics
- Colorectal Cancer91 topic
- Screening91 topic
- Cetuximab81 topic
- KRAS Mutations81 topic
- Barrett's Esophagus61 topic
- Esophageal Carcinoma61 topic
- Hereditary Syndromes61 topic
- Imatinib Mesylate61 topic
- Laparoscopic Surgery61 topic
- Lung Tumors61 topic
- Metastatic Carcinomas61 topic
- Microsatellite Instability61 topic
- Rectal Cancer61 topic
- Sunitinib61 topic
Where does Mikio Fujita work?
Mikio Fujita's main affiliation in the publication record is Radiation Effects Research Foundation, Japan.
How many publications and citations does Mikio Fujita have?
OpenAlex counts 97 works and 1,538 citations for Mikio Fujita, an h-index of 21, ranking #4,414,601 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mikio Fujita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.